Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease

G Mercado, V Castillo, P Soto, N López, JM Axten… - Neurobiology of …, 2018 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder, leading
to the progressive decline of motor control due to the loss of dopaminergic neurons in the …
被引用次数：148 相关文章

Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.

G Mercado, V Castillo, P Soto, N López… - Neurobiology of …, 2018 - europepmc.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder, leading
to the progressive decline of motor control due to the loss of dopaminergic neurons in the …

Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease

G Mercado, V Castillo, P Soto… - Neurobiology of …, 2018 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disorder, leading
to the progressive decline of motor control due to the loss of dopaminergic neurons in the …

Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease

G Mercado, V Castillo, P Soto… - Neurobiology …, 2018 - researchinformation.amsterdamumc …
Parkinson's disease (PD) is the second most common neurodegenerative disorder, leading
to the progressive decline of motor control due to the loss of dopaminergic neurons in the …

Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease

G Mercado, V Castillo, P Soto, N López, JM Axten… - 2018 - repositorio.uchile.cl
© 2018 Elsevier Inc. Parkinson's disease (PD) is the second most common
neurodegenerative disorder, leading to the progressive decline of motor control due to the …